Mynx M5 One Hour Ambulation Study

Inclusion Criteria: * Patient is \> 18 years of age * Patient underwent a percutaneous diagnostic procedure utilizing a 5F procedural sheath in the common femoral artery * Patient has been informed and understands the nature of the study and provides written INformed COnsent approved by the appropriate Institutional Review Board (IRB) prior to enrollment * Patient is able to ambulate (routinely walk 6 meters or 20 feet without assistance for any reason) as assessed by the investigator Exclusion Criteria: Pre-Procedure Exclusion Criteria * Patient had a prior surgical procedure, PTA, stent placement, or vascular graft in the common femoral artery * Patient has a bleeding disorder such as thrombocytopenia * Patient has uncontrolled hypertension * Patient is morbidly obese (BMI \>40 kg/m2 * Patient is pregnant or lactating * Patient has a documented INR \>1.5 or patients currently receiving glycoprotein IIb/IIIa platelet inhibitor * Patient has a known severe allergy to contrast medium * Patient has a known allergy to PEG * Patient is unable to ambulate at one hour secondary to a co-morbid condition * Patient is know to require an extended hospitalization or re-hospitalization (e.g.patient is undergoing coronary artery bypass graft (CABG) surgery) or patient is scheduled to have a CABG surgery \<30 days following the procedure Intra-Procedure Exclusion Criteria * Common femoral artery is \<5mm in diameter * Patient with clinically significant peripheral vascular disease in the vicinity of the puncture * Puncture site is located above the most inferior border of the inferior epigastric artery (IEA) and/or above the inguinal ligament based upon bony landmarks * Patient has a posterior puncture or multiple punctures in an attempt to gain access * Patient has an ipsilateral venous sheath * Patient has a pre-existing arterial bleed/extravasation identified on pre-procedure femoral arteriogram, hematoma, pseudoaneurysm or arteriovenous fistula present prior to sheath removal * Patient has intra-procedural bleeding around the access site prior to sheath removal